These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 15709166)

  • 1. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance.
    Hoffmann TK; Dworacki G; Tsukihiro T; Meidenbauer N; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2002 Aug; 8(8):2553-62. PubMed ID: 12171883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell apoptosis and suppression of T-cell receptor/CD3-zeta by Fas ligand-containing membrane vesicles shed from ovarian tumors.
    Taylor DD; Gerçel-Taylor C; Lyons KS; Stanson J; Whiteside TL
    Clin Cancer Res; 2003 Nov; 9(14):5113-9. PubMed ID: 14613988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-induced apoptosis of T cells: amplification by a mitochondrial cascade.
    Gastman BR; Yin XM; Johnson DE; Wieckowski E; Wang GQ; Watkins SC; Rabinowich H
    Cancer Res; 2000 Dec; 60(24):6811-7. PubMed ID: 11156370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles.
    Martínez-Lorenzo MJ; Anel A; Gamen S; Monle n I; Lasierra P; Larrad L; Piñeiro A; Alava MA; Naval J
    J Immunol; 1999 Aug; 163(3):1274-81. PubMed ID: 10415024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma.
    Dworacki G; Meidenbauer N; Kuss I; Hoffmann TK; Gooding W; Lotze M; Whiteside TL
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):947s-957s. PubMed ID: 11300496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
    Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated caspase-3 activity in peripheral blood T cells coexists with increased degree of T-cell apoptosis and down-regulation of TCR zeta molecules in patients with gastric cancer.
    Takahashi A; Kono K; Amemiya H; Iizuka H; Fujii H; Matsumoto Y
    Clin Cancer Res; 2001 Jan; 7(1):74-80. PubMed ID: 11205921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?
    Bohana-Kashtan O; Civin CI
    Clin Cancer Res; 2005 Feb; 11(3):968-70. PubMed ID: 15709161
    [No Abstract]   [Full Text] [Related]  

  • 15. Human retinal pigment epithelial cell-induced apoptosis in activated T cells.
    Jørgensen A; Wiencke AK; la Cour M; Kaestel CG; Madsen HO; Hamann S; Lui GM; Scherfig E; Prause JU; Svejgaard A; Odum N; Nissen MH; Röpke C
    Invest Ophthalmol Vis Sci; 1998 Aug; 39(9):1590-9. PubMed ID: 9699548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
    Crowe DL; Boardman ML; Fong KS
    Anticancer Res; 1998; 18(5A):3163-70. PubMed ID: 9858879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis.
    Dick AD; Siepmann K; Dees C; Duncan L; Broderick C; Liversidge J; Forrester JV
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2258-67. PubMed ID: 10476791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fas mediates apoptosis and oxidant-induced cell death in cultured hRPE cells.
    Jiang S; Wu MW; Sternberg P; Jones DP
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):645-55. PubMed ID: 10711676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial ovarian cancer cells secrete functional Fas ligand.
    Abrahams VM; Straszewski SL; Kamsteeg M; Hanczaruk B; Schwartz PE; Rutherford TJ; Mor G
    Cancer Res; 2003 Sep; 63(17):5573-81. PubMed ID: 14500397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.